Skip to content
DraconiticResearch
Search Sources API
197,768 studies31 sourcesUpdated 30 min ago
Peer-reviewedCC BYFrontiers in immunology

Case Report: CD20/BCMA bispecific CAR-T therapy for progressive multiple sclerosis

  • Zhenfen Ling1
  • Xia Liu1
  • Wensi Li2
  • Qingguo Wang1
  • Nu Tan1
  • Xueying Ding1
  • Yunyi Zan1
  • Youyao Gu2
  • Yuan Qian2
  • Xiaobing Luo3
  • Thule Trinh3
  • Yanfeng Li2
10 more authors
  • Xiaoteng Lv2
  • Minna Wang2
  • Qian Tan2
  • Kevin Zhu4
  • Chengxiao Zheng2
  • Xin Yao3
  • Judy Zhu2
  • Jiaqi Huang3
  • Yihong Yao3
  • Nan Shen5
5 affiliations
  1. 1Shanghai General Hospital , ,
  2. 2Shanghai AbelZeta Ltd. , ,
  3. 3AbelZeta Inc. , , ,
  4. 4The University of Vermont Medical Center , , ,
  5. 5Renji Hospital, Shanghai Jiao Tong University School of Medicine , ,
Read full textPDFCite

Related

  1. Mesenchymal stromal cells for progressive multiple sclerosis: current evidence and translational challenges
    Laure Michel, Lucie Rio, Karin Tarte
    CytotherapyPeer-reviewedCC BY 4.0Full textGeneral biologyOncologyHAL
  2. Neuroinflammatory Imaging Biomarkers: Relevance to Multiple Sclerosis and its Therapy
    Thomas Tourdias, Vincent Dousset
    NeurotherapeuticsPeer-reviewedLicence not statedFull text30 citedNeuroscienceHAL
  3. Case Report: Eosinophilic granulomatosis with polyangiitis presenting as a multiple sclerosis mimic
    Benjamin Landau, Michael Kettner, Mathias Fousse +4
    Frontiers in ImmunologyPeer-reviewedCC BY 4.0Full textImmunologyCrossrefEurope PMCPMCEurope PMC
  4. Unilateral MR-guided laser interstitial thermal therapy thalamotomy for refractory multiple sclerosis tremor: 12-month outcomes in four patients
    Mickael Aubignat, Mélissa Tir, Martial Ouendo +5
    Multiple Sclerosis and Related DisordersPeer-reviewedCC BYFull textNeuroscienceHAL
  5. Efficacy and specific toxicity profiles of GPRC5D- versus BCMA-targeted bispecific antibodies in relapsed/refractory multiple myeloma: a meta-analysis of clinical trials and real-world studies
    Jiahao Ji, Xinyu Zhao, Bin Wang +2
    Frontiers in immunologyPeer-reviewedCC BYFull textImmunologyEurope PMC

Cite

BibTeXRIS
BibTeX
@article{ling2026case,
  title = {{Case Report: CD20/BCMA bispecific CAR-T therapy for progressive multiple sclerosis}},
  author = {Zhenfen Ling and Xia Liu and Wensi Li and Qingguo Wang and Nu Tan and Xueying Ding and Yunyi Zan and Youyao Gu and Yuan Qian and Xiaobing Luo and Thule Trinh and Yanfeng Li and Xiaoteng Lv and Minna Wang and Qian Tan and Kevin Zhu and Chengxiao Zheng and Xin Yao and Judy Zhu and Jiaqi Huang and Yihong Yao and Nan Shen},
  journal = {Frontiers in immunology},
  year = {2026},
  month = oct,
  url = {https://europepmc.org/article/PMC/PMC13658549},
  note = {CC BY},
}
RIS
TY  - JOUR
TI  - Case Report: CD20/BCMA bispecific CAR-T therapy for progressive multiple sclerosis
AU  - Zhenfen Ling
AU  - Xia Liu
AU  - Wensi Li
AU  - Qingguo Wang
AU  - Nu Tan
AU  - Xueying Ding
AU  - Yunyi Zan
AU  - Youyao Gu
AU  - Yuan Qian
AU  - Xiaobing Luo
AU  - Thule Trinh
AU  - Yanfeng Li
AU  - Xiaoteng Lv
AU  - Minna Wang
AU  - Qian Tan
AU  - Kevin Zhu
AU  - Chengxiao Zheng
AU  - Xin Yao
AU  - Judy Zhu
AU  - Jiaqi Huang
AU  - Yihong Yao
AU  - Nan Shen
PY  - 2026
DA  - 2026/10/16
JO  - Frontiers in immunology
UR  - https://europepmc.org/article/PMC/PMC13658549
SN  - 1664-3224
ER  -